Keywords: actelion, renew, research, deal, switzerland, rw, johnson
Actelion and J&J renew research deal
Article | 27 June 2001
Actelion of Switzerland and the RW Johnson Pharmaceutical ResearchInstitute, part of the Johnson & Johnson group, have extended their research cooperation ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
